Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2.

Abraham S, Pahwa R, Ye C, Choi JG, Pahwa S, Jaggaiahgari S, Raut A, Chen S, Manjunath N, Shankar P.

PLoS One. 2012;7(12):e51832. doi: 10.1371/journal.pone.0051832. Epub 2012 Dec 18.

2.

Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.

Ali N, Flutter B, Sanchez Rodriguez R, Sharif-Paghaleh E, Barber LD, Lombardi G, Nestle FO.

PLoS One. 2012;7(8):e44219. doi: 10.1371/journal.pone.0044219. Epub 2012 Aug 28.

3.

Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.

Zheng J, Liu Y, Liu Y, Liu M, Xiang Z, Lam KT, Lewis DB, Lau YL, Tu W.

Sci Transl Med. 2013 Jan 16;5(168):168ra9. doi: 10.1126/scitranslmed.3004943.

4.

Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.

Scalapino KJ, Daikh DI.

PLoS One. 2009 Jun 24;4(6):e6031. doi: 10.1371/journal.pone.0006031.

5.

Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).

Cao T, Soto A, Zhou W, Wang W, Eck S, Walker M, Harriman G, Li L.

Cell Immunol. 2009;258(1):65-71. doi: 10.1016/j.cellimm.2009.03.013. Epub 2009 May 1.

PMID:
19410243
6.

Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.

Pino S, Brehm MA, Covassin-Barberis L, King M, Gott B, Chase TH, Wagner J, Burzenski L, Foreman O, Greiner DL, Shultz LD.

Methods Mol Biol. 2010;602:105-17. doi: 10.1007/978-1-60761-058-8_7.

7.

Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.

Yang J, Fan H, Hao J, Ren Y, Chen L, Li G, Xie R, Yang Y, Qian K, Liu M.

Transfusion. 2012 Jun;52(6):1333-47. doi: 10.1111/j.1537-2995.2011.03448.x. Epub 2011 Nov 21.

PMID:
22098312
8.

Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.

Janikashvili N, Trad M, Gautheron A, Samson M, Lamarthée B, Bonnefoy F, Lemaire-Ewing S, Ciudad M, Rekhviashvili K, Seaphanh F, Gaugler B, Perruche S, Bateman A, Martin L, Audia S, Saas P, Larmonier N, Bonnotte B.

J Allergy Clin Immunol. 2015 Jun;135(6):1614-24.e4. doi: 10.1016/j.jaci.2014.12.1868. Epub 2015 Jan 25.

PMID:
25630940
9.
10.

Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.

Turgeon NA, Banuelos SJ, Shultz LD, Lyons BL, Iwakoshi N, Greiner DL, Mordes JP, Rossini AA, Appel MC.

Exp Biol Med (Maywood). 2003 Oct;228(9):1096-104.

PMID:
14530522
11.

[Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].

Gao L, Wang JM, Xie LN, Zhou H, Qiu HY.

Zhonghua Xue Ye Xue Za Zhi. 2008 Feb;29(2):87-91. Chinese.

PMID:
18681307
12.

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.

Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, McKenna DH, Bromberg JS, Levine BL, Riley JL, June CH, Scheinberg P, Douek DC, Miller JS, Wagner JE, Blazar BR.

Sci Transl Med. 2011 May 18;3(83):83ra41. doi: 10.1126/scitranslmed.3001809.

13.

Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.

Sato K, Eizumi K, Fukaya T, Fujita S, Sato Y, Takagi H, Yamamoto M, Yamashita N, Hijikata A, Kitamura H, Ohara O, Yamasaki S, Saito T, Sato K.

Blood. 2009 May 7;113(19):4780-9. doi: 10.1182/blood-2008-10-183145. Epub 2009 Feb 19.

14.

Human T cells depend on functional calcineurin, tumour necrosis factor-α and CD80/CD86 for expansion and activation in mice.

Søndergaard H, Kvist PH, Haase C.

Clin Exp Immunol. 2013 May;172(2):300-10. doi: 10.1111/cei.12051.

15.

Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.

Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, Olivier M, Piccirillo CA.

PLoS One. 2012;7(4):e35572. doi: 10.1371/journal.pone.0035572. Epub 2012 Apr 24.

16.

Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.

Fujii H, Luo ZJ, Kim HJ, Newbigging S, Gassas A, Keating A, Egeler RM.

PLoS One. 2015 Jul 15;10(7):e0133216. doi: 10.1371/journal.pone.0133216. eCollection 2015.

17.

NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.

Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T, Greiner DL.

J Immunol. 2000 Mar 1;164(5):2496-507.

18.

Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.

Berney T, Molano RD, Pileggi A, Cattan P, Li H, Ricordi C, Inverardi L.

Transplantation. 2001 Jul 15;72(1):133-40.

PMID:
11468548
19.

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF.

Exp Hematol. 2007 Dec;35(12):1823-38. Epub 2007 Aug 30.

20.

Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.

Pankratz S, Bittner S, Herrmann AM, Schuhmann MK, Ruck T, Meuth SG, Wiendl H.

FASEB J. 2014 Aug;28(8):3435-45. doi: 10.1096/fj.14-251074. Epub 2014 Apr 17.

Supplemental Content

Support Center